Back to results
US 6,617,343 B1Granted
Hypoglycemic N,N-arylsulfonylglycine compounds
AssigneeEli Lilly and Company
InventorSamuel James Dominianni
Life of this patent
Estimating the term…
Abstract
A compound of formula l: wherein, R1, R2 and R3 independently represent hydrogen, alkyl, alkenyl, alkynyl, aryl, or aralkyl groups having 1 to 8 carbon atoms; X represents an alkoxyalkyl, alkoxyaryl, alkoxyalkylaryl, aralkylalkoxy, or alkoxyalkylheterocycle; or a pharmaceutically acceptable salt or prodrug thereof.
Claims9
A compound of formula I:
- wherein,
- R1, R2, and R3 independently represent hydrogen, alkyl, alkenyl, alkynyl, aryl, or aralkyl groups having 1 to 8 carbon atoms;
- X represents an alkoxyalkyl, alkoxyaryl, alkoxyalkylaryl, aralkylalkoxy, or alkoxyalkylheterocycle;
- or a pharmaceutically acceptable salt or prodrug thereof.
1 more element
A compound selected from the group consisting of:
- N-[4-(2-(Phenyloxazol-4yl)ethoxy)phenyl]-N-isopropyl sulfonylglycine represented by the formula:
- N-4[-(2-(Phenyloxazol-4yl)ethoxy)phenyl]-N-methylsufonyl-glycine represented by the formula:
- N-[4-(2-(Phenyloxazol-4yl)ethoxy)phenyl]-N-N′N′-dimethyl aminosulfonylglycine represented by the formula:
- N-[4-(2-(Phenyloxazol-4yl)ethoxy)phenyl]-N-phenylmethyl sulfonylglycine represented by the formula:
- and,
- N-[5-(2-(2-Naphthylmethyl)benzofuranyl)]-N-methylsufonyl glycine
- or a pharmaceutically acceptable salt or prodrug thereof.
4 more elements
Dependencies are inferred from the claim text.